×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
PLENARY SESSION
Session Chair(s)
Christina Bucci-Rechtweg, MD
Global Head, Maternal Health and Pediatric Regulatory Policy
Novartis , United States
Speaker(s)
Feedback from Breakout Groups Presented by Rapporteurs
Ronald Portman, MD
Clinical Development & Analytics, Novartis Pharmaceuticals Corporation, United States
Executive Director, Pediatric Development, Science and Innovation
Feedback from Breakout Groups Presented by Rapporteurs
Sue Killion Cammarata, MD
Shire, United States
VP
Feedback from Breakout Groups Presented by Rapporteurs
Genevieve Michaux, LLM
King & Spalding International LLP, Belgium
Partner, Life Sciences
Follow-up on Workshops on Therapeutic Areas – Papers that emanated from them
Ronald Portman, MD
Clinical Development & Analytics, Novartis Pharmaceuticals Corporation, United States
Executive Director, Pediatric Development, Science and Innovation
Paediatric Regulation: Five years of success
Paolo Tomasi, MD, PhD
European Medicines Agency, Netherlands
Head of Paediatric Medicines
Paolo Tomasi, MD, PhD
European Medicines Agency, Netherlands
Head of Paediatric Medicines
Have an account?